Literature DB >> 6397566

Lipoprotein metabolism in experimental nephrosis.

J B Marsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397566

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  10 in total

1.  (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.

Authors:  Yayoi Saegusa; Chiharu Sadakane; Junichi Koseki; Yoshihiro Hasegawa; Shoichiro Shindo; Shuichi Takeda; Hiroshi Takeda; Tomohisa Hattori
Journal:  Clin Exp Nephrol       Date:  2010-09-04       Impact factor: 2.801

2.  Effects of low casein and fish oil on hyperlipidemia and proteinuria in nephritic rats.

Authors:  K Fujisawa; K Yagasaki; R Funabiki
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

3.  Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

Authors:  R W Davies; I Staprans; F N Hutchison; G A Kaysen
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1.

Authors:  M Zaiou; N Azrolan; T Hayek; H Wang; L Wu; M Haghpassand; B Cizman; M P Madaio; J Milbrandt; J B Marsh; J L Breslow; E A Fisher
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Hepatic cholesterol metabolism in experimental nephrotic syndrome.

Authors:  A al-Shurbaji; E Humble; M Rudling; B Lindenthal; L Berglund
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

Review 6.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

Review 7.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

8.  Lipoprotein profiles at different stages of the nephrotic syndrome.

Authors:  U Querfeld; A Gnasso; W Haberbosch; J Augustin; K Schärer
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

9.  Macrophages from nephrotic rats regulate apolipoprotein E biosynthesis and cholesterol content independently.

Authors:  J Bass; E A Fisher; M M Prack; D L Williams; J B Marsh
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Effects of dietary protein and fat contents on renal function and inflammatory cytokines in rats with adriamycin-induced nephrotic syndrome.

Authors:  Su Yeon Kim; A Young Lim; Su Kyung Jeon; In Seok Lee; Ryowon Choue
Journal:  Mediators Inflamm       Date:  2011-05-24       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.